Phase 1 N=20 Reperfusion With Cooling in Cerebral Acute Ischemia
Stroke, Acute
Primary: Number of Participants With Reperfusion Injury Hemorrhagic Transformation — 3 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=509 (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
Ulcerative Colitis
Primary: Clinical and Endoscopic Remission. — 13.2; 17.9; 7.4; 12.1 percentage of patients — p=0.1393
Phase 3 N=41 Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus
Strabismus
Primary: Change From Baseline in Strabismus Angle Prism Dioptre (PD) in the Primary Position at Week 4 of the FTP in Observed Cases (OC) — 2.33; -7.50; -3.75; -0.55 prism dioptre…
N/A N=25 Atrial Fibrillation Recurrence in Sleep Apnea
Sleep Apnea · Atrial Fibrillation
Primary: Number of Subjects Who Had Atrial Fibrillation Recurrence at 1 Year — 3; 3 participants
Phase 2 N=30 CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
Non-Hodgkin Lymphoma · Mycosis Fungoides
Primary: Objective Response Rate (ORR) — 26.7; 35.7 percentage of treated subjects
Phase 4 N=100 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
Cellulitis · Skin Infections
Primary: Satisfaction of Discharge Criteria — 15; 14 participants
N/A N=235 Point-of-Care Glucose Testing and Insulin Supplementation
Diabetes
Primary: Mean Fasting Blood Glucose — 162; 157 mg/dL
Phase 3 N=460 A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)
Sleep Initiation and Maintenance Disorders · Mental Disorders · Dyssomnias
Primary: Change From Baseline in Total Sleep Time (TST) - 6-Month Treatment Period — 65.9; 19.3 minutes — p=<0.0001
Phase 2 N=739 Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma
Asthma
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) — 2.139; 2.071; 2.187; 2.162 Liters
Phase 3 N=100 Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Parenteral Nutrition
Primary: Number of New Nosocomial Infections After 48 Hrs of Parenteral Nutrition (PN) Between the 2 Groups During Their Hospital Stay — 21; 29 number of nosocomial infections
Phase 1 N=48 Computer-delivered Screening and Brief Intervention for Alcohol Use in Pregnancy
Alcohol Abuse
Primary: Alcohol Use — 18; 14 participants
N/A N=92 The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions
Post-operative Complications · Surgical Site Infection · Surgical Wound Infection
Primary: Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. — 7; 2 participants
Phase 3 N=410 (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
Ulcerative Colitis
Primary: Clinical and Endoscopic Remission. — 8.3; 17.4; 12.6; 4.5 percentage of patients — p=0.2876
Phase 3 N=327 Concurrent Bupropion / Varenicline for Smoking Cessation
Nicotine Dependence
Primary: Four-week Continuous Abstinence From Cigarette Smoking — 25.93; 46.94; 43.64; 39.82 percentage of participants
N/A N=852 Safety and Effectiveness Study of Prodisc to Spinal Fusion Surgery
Spinal Diseases
Primary: Overall Success — 45.1; 63.5; 66.7; 53.3 percentage of overall successes